The Italian health ministry is appointing a new a director-general to AIFA, the Italian medicines regulatory body, following the investigation of a commission into the performance of the agency.
Guido Rasi, professor of microbiology and director of administration at the Superior Institute of Health will charged with reforming AIFA, through maintaining budgets and enforcing deadlines for the registration of medicines.
This change will be carried out initially using existing legislation and regulatory procedures, although the reform might utilise recent legislation allowing for the reorganisation of public institutions.
Undersecretary to the Ministry of Labour, Health and Social Policies, Prof Ferruccio Fazio, said that according to the report into AIFAâ€™s activities, the agency was generally effective in pharmaceutical spending, and staff showed a high level of professionalism.
However, AIFA was found to be lacking in other areas, such as delays in regulatory and registrations activity.